Prime Research

Latest Research

Prader-Willi Syndrome may get a new treatment option in late December

Prader-Willi syndrome (PWS) is a genetic, multi-system disorder that affects approximately 9,000 to 10,000 individuals in the United States. Its symptoms and their severity vary…

Read More

Biosimilar strategy for bevacizumab using MedDrive™

Avastin® (bevacizumab) from Genentech was first approved in 2004. It has received FDA approval for treatment of:1 advanced colon cancer (2004) advanced lung cancer (2006)…

Read More

Drug Pipeline Update: November 2021

This monthly pipeline wrap up provides a review of newly approved drugs, recent drug launches, generic updates, new indications and news of note on drugs…

Read More
Select a Research Type
Drug pipeline updates
Prime analysis
Scientific presentations
Loading …